Yeah, wont be getting my uptake either for a number of reasons.
News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-39
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
-0.002(2.47%) |
Mkt cap ! $81.90M | |||
| Open | High | Low | Value | Volume |
| 8.0¢ | 8.0¢ | 7.9¢ | $111.6K | 1.406M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 824449 | 7.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 282614 | 3 |
View Market Depth
| Last trade - 10.58am 01/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |